Top Markets
Coin of the day
Elicio Therapeutics, Inc. Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc.

ELTX
Rangering i aksjer #24601
Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to... Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating a diverse array of innovative immunotherapies for the treatment of various cancers and other diseases. The company's primary experimental drug, ELI-002, is an AMP therapeutic vaccine specifically formulated to target KRAS-driven cancers. Its development portfolio also encompasses ELI-004, an AMP-modified CpG adjuvant that forms part of ELI-002; ELI-007, a lymph node-targeted AMP-peptide vaccine addressing mutant BRAF-driven cancers; and ELI-008, a multivalent lymph node-targeted AMP-peptide vaccine for cancers expressing mutant TP53. Furthermore, Elicio is advancing ELI-005, a vaccine candidate for preventing COVID-19, and ELI-011 for hematological malignancies. Another program, ELI-012, is an mKRAS TCR T cell AMP-lifier designed for combined use with mKRAS-targeted TCR T cell therapy against mKRAS-driven cancers. The company's operations are headquartered in Boston, Massachusetts.
Aksjekurs
$3.09
Markedsverdi
$58.82M
Endring (1 dag)
0.33%
Endring (1 år)
-73.01%
Land
US
Handel Elicio Therapeutics, Inc. (ELTX)

Kategori

Aksjeprishistorikk for Elicio Therapeutics, Inc. (ELTX)
Høyeste sluttskurs: $3.10 den 2026-08-01

Laveste sluttskurs: $5.88 den 2023-11-01
Aksjeprishistorikk for Elicio Therapeutics, Inc. fra 2023 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 9.17%
2025 59.27%
2024 -21.55%
2023 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$550.26 38.44%
US
$1.05K 58.16%
NL
$148.90 467.89%
US
$118.70 -18.24%
AU
$770.19 9.84%
CH